Retatrutide × Kensington Labs - Lab Test, July 2025
Test results
About this test
Retatrutide 10mg from Kensington Labs achieved 99.076% purity in independent HPLC analysis conducted by Janoshik Labs on July 10, 2025. The tested quantity of 10.76mg exceeds the labeled 10mg specification, indicating accurate labeling and manufacturing quality.
Retatrutide is a triple GIP/GLP-1/GCG receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level of 99.076% confirms minimal contamination and high-grade synthesis quality.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key FCZ54187G2MD.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.